Director Kevin B. Churchwell resigns from Cyclerion board effective Aug 18, 2021

Cyclerion Therapeutics, Inc.

Kevin B. Churchwell, M.D. resigned from the board of directors on August 18, 2021.
No disagreement with company operations, policies, or practices cited.
Resignation due to expanded responsibilities as CEO of Boston Children's Hospital.
Marsha Fanucci, Board Chair, thanked Churchwell for his service.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kevin B. Churchwell, M.D.

Director

CYCN · Cyclerion Therapeutics, Inc.

Effective: 2021-08-18
Filed: August 19, 2021, 7:59 PM ET

On and effective August 18, 2021, Kevin B. Churchwell, M.D., resigned from the board of directors of Cyclerion Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Kevin B. Churchwell, M.D. resigned as Director at Cyclerion Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On and effective August 18, 2021, Kevin B. Churchwell, M.D., resigned from the board of directors of Cyclerion Therapeutics, Inc.

View on SEC.gov

Cyclerion Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-21-028904

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.